WILSON TROY EDWARD 4
4 · Kura Oncology, Inc. · Filed Sep 9, 2025
Insider Transaction Report
Form 4
WILSON TROY EDWARD
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2025-09-08$8.20/sh+50,000$410,145→ 100,968 total
Holdings
- 279,194(indirect: By Trust)
Common Stock
- 300,000(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]This transaction was executed in multiple trades at prices ranging from $8.135 to $8.24. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakesto provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.